New Mexico 2025 Regular Session

New Mexico House Bill HB152

Introduced
1/28/25  

Caption

Medically Assisted Treatment For Juveniles

Impact

The bill's implementation means that facilities that restrict MAT for minors will no longer be eligible for Medicaid reimbursements. This shift is expected to incentivize facilities to adopt evidence-based treatments that include MAT, as financial support will be contingent upon compliance with the new regulations. By pressing for standardized treatment approaches, HB152 seeks to improve care outcomes for young individuals facing substance dependencies.

Summary

House Bill 152 aims to ensure that minors undergoing treatment for substance use disorders have access to medication-assisted treatment (MAT) across various state-operated facilities. The bill specifically prohibits inpatient substance use treatment facilities, outpatient programs, and juvenile justice facilities from implementing restrictions on the use of MAT for minors. It establishes regulations that will come into effect on July 1, 2026, which could potentially impact the treatment landscape for adolescents struggling with substance use issues.

Contention

While the bill is largely supportive of public health interests, it could spark debates regarding the appropriateness and logistics of MAT for minors. Some stakeholders may argue that certain MATs, based on their side effects and the developmental stage of adolescents, might not always be in the best interest of young patients. Furthermore, concerns could arise about ensuring that adequate training and resources are provided to healthcare providers in these facilities to effectively administer MAT.

Companion Bills

No companion bills found.

Similar Bills

WI AB925

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

WI SB904

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

NH HB751

Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.

PA SB691

Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

MO SB218

Modifies provisions relating to court operations

MA H2227

Replacing archaic and stigmatizing language for substance use

NJ S810

Authorizes outpatient substance use disorder treatment programs to make housing available under certain circumstances.

MS HB718

Opioid use disorder; require substance use disorder facilities to provide pregnant women with onsite access to certain treatments.